Chronic kidney disease: Metformin increases risk of mortality in patients with advanced chronic kidney disease

Nature Reviews Nephrology 11, 443 (2015). doi:10.1038/nrneph.2015.110 Author: Jessica K. Edwards The use of metformin in patients with type 2 diabetes mellitus (T2DM) and advanced chronic kidney disease (CKD) confers a 35% increased risk of all-cause mortality compared to those not treated with metformin, according to new findings published in The Lancet Diabetes & Endocrinology.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Research Highlight Source Type: research